Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,897 followers.

Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression https://t.co/8UKHkCgVpX https://t.co/zZ1ocfCvmf

16 Dec 2022

Reply Repost Favourite

New Research: Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression https://t.co/2ztT3xGiGJ #pharmacology

29 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.